《Table 4Summary of early recurrence rate and 2-year disease-free survival in subgroups of patients c

《Table 4Summary of early recurrence rate and 2-year disease-free survival in subgroups of patients c   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Novel biomarkers GEP/ABCB5 regulate response to adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录
TACE:transarterial chemoembolization;GEP:Granulin-epithelin precursor;ABC:ATP-dependent binding cassette;NA:not available.

Another 14 patients(7 adjuvant TACE,7 control)had both GEP positive and ABCB5 positive(GEP+/ABCB5+)and were classified as high risk group.Among this risk group,5/7(71.4%)patients in the adjuvant TACE arm and 2/7(28.6%)patients in the control arm had early intrahepatic recurrence.There were no significant differences in the early recurrence rate,2-year disease-free survival and overall survival between adjuvant TACE and control arms(P=0.286,P=0.088,P=0.392,respectively)(Table 4) .